Good signs ...., page-265

Growth of market

The medical-imaging market size globally was valued at $38.5 billion in 2020 and is forecast to reach $68.8 billion by 2030, growing at a CAGR of 5.8% from 2021 to 2030.
Among factors contributing to the growth is an ageing population along with greater demand by treating doctors for enhanced optical images for better diagnosis.
An emerging approach to maximising therapeutics’ effectiveness by taking into account individual variability in genetic and environmental factors known as precision medicine is also contributing to growth.
Here are some ASX-listed medical imaging stocks that could benefit from sector growth:



OIL is a leader in development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications.
The company’s tech enables real-time, in vivo imaging at the cellular level in human and animal tissue and is used by leading research institutions and hospitals in North America, Europe, Asia and Australia.
Its goal is to support medical practitioners and researchers in providing better outcomes while saving resources for healthcare providers.
It helps surgeons make instantaneous decisions in operating theatres to improve patient outcomes and has potential to revolutionise clinical practice, cancer surgery and life sciences research.
The company recently announced positive interim results of its oral imaging study conducted by Professor Farah and his team at the Australian Centre for Oral Oncology Research & Education.
The results show that diagnostic accuracy was extremely high at 88.9% for the presence of dysplasia/carcinoma.



re- posted